Baader Bank Aktiengesellschaft Regeneron Pharmaceuticals, Inc. Transaction History
Baader Bank Aktiengesellschaft
- $1.45 Billion
- Q4 2024
A detailed history of Baader Bank Aktiengesellschaft transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Baader Bank Aktiengesellschaft holds 866 shares of REGN stock, worth $486,250. This represents 0.04% of its overall portfolio holdings.
Number of Shares
866
Previous 945
8.36%
Holding current value
$486,250
Previous $993,000
37.97%
% of portfolio
0.04%
Previous 0.06%
Shares
11 transactions
Others Institutions Holding REGN
# of Institutions
1,496Shares Held
87.1MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.21 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.74 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$3.96 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.71 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$2.66 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $60.2B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...